Medical Marijuana Patients Report Marked Reduction in Pain, Shows Preliminary Research

0
131

Medical Marijuana Patients Report Marked Reduction in Pain, Shows Preliminary ResearchBefore patients can be allowed to purchase medical marijuana in the only licensed facility in South Jersey, they must select one animated face among the six provided on the form provided.

The form, called the Wong-Baker FACES Pain Rating Scale, is used to classify the degree the patient is experiencing due to epilepsy, multiple sclerosis, cancer and other conditions. When the patients visit the Compassionate Care Foundation dispensary again to buy another dose, they are given the form to analyze the effect of the drug.

“The results so far are absolutely dramatic,” said Suzanne Miller, Ph.D. Miller is a director and professor of behavioral medicine at Fox Chase Cancer Center/Temple Health in Philadelphia. She also sits on the board of trustees of the dispensary.

**relatedarticle**

Roughly 80 percent of the 145 dispensary patients who filled the forms at least twice in the past two months have recorded marked improvement in their condition, said Miller. While the research is still ongoing, Miller revealed that patients said their pain levels have reduced by 30 percent to 50 percent.

“You usually see smaller results, about 10 percent, or 20 percent,” she said, according to Philly.com.

Miller, who has authored four books and contributed to over 100 academic papers, plans to submit the report for publication by medical journals probably in the fall. The medical marijuana facility has 600 patients on its register, and expects to collect enough data before the fall. Cannabis in the dispensary is sold at $428 per ounce, and is packaged in plastic bottles.

New Jersey is among the 22 U.S. states that have decriminalized medical cannabis. However, the drug is still considered illegal under the federal law. To register for a free 2-week subscription to ForexMinute Premium Plan, visit www.forexminute.com/newsletter.

To contact the reporter of this story; Jonathan Millet at john@forexminute.com